The extended recovery ring-stage survival assay provides a superior association with patient clearance half-life and increases throughput

Table 1 Parasite isolates used in this study

Isolate	kelch13 mutation	PC_1/2	Location	Year
NHP1333	N458I	9.24	MKT	2011
NHP1455	R561H	8.02	MKT	2012
NHP1337	C580Y	7.83	MKT	2011
NHP4333	C538V	7.7	WPA	2008
NHP4373	WT	7.1	WPA	2008
NHP3035	M476I	6.16	MLA	2008
NHP4078	A675V	5.82	WPA	2008
NHP4201	WT	5.65	WPA	2008
NHP4106	WT	5.54	WPA	2008
NHP4673	E252Q	5.34	WPA	2010
NHP4748	WT	2.89	WPA	2011
NHP4072	WT	2.29	WPA	2008
NHP3032	K438N	2.17	MLA	2008
NHP4302	WT	1.98	WPA	2008
NHP1386	WT	1.67	MKT	2011

Overview of 15 parasite isolates used in this study. Patient clearance rates were calculated with [5]. Location of isolate collection and year of collection are as reported from Phyo et al. [19], Taylor et al. [28], and Cheeseman et al. [29]. Samples were all collected from clinics on the northwestern border of Thailand
MKT: Mawker Thai, MLA: Maela, and WPA: Wang Pha

ISSN: 1475-2875